Senn Chemicals

Granules India Buys Swiss CDMO Senn Chemicals

Indian pharmaceutical company Granules India has agreed to acquire Senn Chemicals, a Swiss-based contract development and manufacturing organization (CDMO) specializing in peptides. The closing of the deal, which is subject to certain conditions, is expected to occur in the first half of 2025. Financial details of the transaction were not disclosed.

Topics • Technology

Earning a Large Chunk of the Cake

Topics • Technology

M&A in Pharma and CRO/CMO Industry

Top-Feature

Agilent Technologies Inc.

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy

CHEManager c/o Wiley-VCH Verlag

Upcoming Virtual Events

BIO Deutschland e.V.

German Biotech Days 2026: Biotechnology as The Key to Industrial Competitiveness

Aenova Holding GmbH

Small Molecules: Choosing a Strategic, Scalable, and De-Risked Development Path

Expert Insights

Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.